We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+27%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$568M
AUM Growth
+$55.3M
(+11%)
Cap. Flow
+$7.09M
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
82.48%
Holding
77
New
5
Increased
9
Reduced
4
Closed
4
Avg Time Held
2.9
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kazia Therapeutics
KZIA
|
+$3.41M |
| 2 |
Precision BioSciences
DTIL
|
+$3.33M |
| 3 |
Pixelworks
PXLW
|
+$1.54M |
| 4 |
GPGI Inc
GPGI
|
+$1.1M |
| 5 |
EyePoint Inc
EYPT
|
+$850K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$3M |
| 2 |
CompoSecure Inc Warrant
CMPOW
|
+$1.28M |
| 3 |
5E Advanced Materials
FEAM
|
+$997K |
| 4 |
Evoke Pharma
EVOK
|
+$728K |
| 5 |
Structure Therapeutics
GPCR
|
+$408K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 37.76% |
| 2 | Industrials | 28.25% |
| 3 | Healthcare | 13.73% |
| 4 | Technology | 6.13% |
| 5 | Materials | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
PayPal
PYPL
$48.9B
| $309K | 0.05% |
5,300
| – | – |
2020 Q1
23 quarters
|
|
52
Cellectar Biosciences
CLRB
$11.2M
| $295K | 0.05% |
100,000
| – | – |
2025 Q3
1 quarter
|
|
53
Otis Worldwide
OTIS
$26.8B
| $262K | 0.05% |
3,000
| – | – |
2020 Q2
22 quarters
|
|
54
Transmedics
TMDX
$2.65B
| $255K | 0.05% |
+2,100
| New | +$264K |
2025 Q4
0 quarters
|
|
55
Bank of New York Mellon
BNY
$96.4B
| $232K | 0.04% |
2,000
| – | – |
2020 Q1
23 quarters
|
|
56
Revolution Medicines Inc Warrant
RVMDW
$108M
| $188K | 0.03% |
200,000
| – | – |
2023 Q4
8 quarters
|
|
57
Alliance Entertainment Holding Corp Warrants
AENTW
| $170K | 0.03% |
200,000
| – | – |
2023 Q2
10 quarters
|
|
58
Cadence Design Systems
CDNS
$89.3B
| $164K | 0.03% |
525
| – | – |
2020 Q2
22 quarters
|
|
59
Lionsgate Studios
LION
$3.28B
| $150K | 0.03% |
16,413
| – | – |
2025 Q3
1 quarter
|
|
60
ExxonMobil
XOM
$718B
| $129K | 0.02% |
1,075
| – | – |
2020 Q2
22 quarters
|
|
61
Palatin Technologies
PTN
$11.6M
| $120K | 0.02% |
+7,800
| New | +$145K |
2025 Q4
0 quarters
|
|
62
SiriusXM
SIRI
$9.15B
| $101K | 0.02% |
5,061
| – | – |
2024 Q3
5 quarters
|
|
63
Beyond Air
XAIR
$2.18M
| $62.8K | 0.01% |
4,324
| – | – |
2024 Q3
5 quarters
|
|
64
ARK Blockchain & Fintech Innovation ETF
ARKF
$912M
| $57.2K | 0.01% |
1,200
| – | – |
2022 Q1
15 quarters
|
|
|
SMTK
65
SmartKem
SMTK
$660K
| $49.6K | 0.01% |
932
-368
| -28% | -$32.9K |
2024 Q4
4 quarters
|
|
66
ARK Next Generation Technology ETF
ARKW
$2.25B
| $44.3K | 0.01% |
300
| – | – |
2022 Q1
15 quarters
|
|
|
67
Revolution Medicines
RVMD
$40.6B
| $44.3K | 0.01% |
556
| – | – |
2023 Q4
8 quarters
|
|
68
GeneDx Holdings
WGS
$2.09B
| $39.5K | 0.01% |
304
| – | – |
2021 Q3
17 quarters
|
|
69
ARK Genomic Revolution ETF
ARKG
$2.09B
| $23.9K | ﹤0.01% |
825
| – | – |
2022 Q1
15 quarters
|
|
70
Starz Entertainment Corp
STRZ
$434M
| $12.8K | ﹤0.01% |
1,092
| – | – |
2025 Q2
2 quarters
|
|
71
X4 Pharmaceuticals
XFOR
$262M
| $2.38K | ﹤0.01% |
595
| – | – |
2019 Q4
24 quarters
|
|
72
SaverOne 2014 Ltd Warrant
SVREW
$63.2K
| $2.22K | ﹤0.01% |
121,000
| – | – |
2022 Q2
14 quarters
|
|
73
Aviat Networks
AVNW
$250M
| $1.41K | ﹤0.01% |
66
| – | – |
2020 Q2
22 quarters
|
|
74
DELISTED
ARKO Corp Warrant
ARKOW
| – | – |
-333,333
| Closed | -$3.1K | – |
|
|
75
DELISTED
CompoSecure Inc Warrant
CMPOW
| – | – |
-100,000
| Closed | -$1.28M | – |
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q4 2025 Portfolio in Review
As of Q4 2025, Bleichroeder LP held 77 positions worth $568M, up 11% from $513M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Bleichroeder LP's Q4 2025 filing shows 5 new, 9 increased, 4 reduced and 4 closed positions. Its largest new stake was Kazia Therapeutics: 400,000 shares worth $2.76M. The largest sale was Linde, an estimated $3M.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Industrials and Healthcare.
- Bleichroeder LP's largest Q4 2025 buy was Kazia Therapeutics: 400,000 shares worth $2.76M.
- Bleichroeder LP added most to Precision BioSciences in Q4 2025, an estimated $3.33M increase.
- Bleichroeder LP's biggest Q4 2025 reduction was Linde, cutting an estimated $3M.
- Bleichroeder LP fully exited CompoSecure Inc Warrant in Q4 2025, selling an estimated $1.28M.
- Bleichroeder LP's ten largest holdings make up 82% of its $568M portfolio in Q4 2025.
- Bleichroeder LP opened 5 new positions and closed 4 in Q4 2025.
- Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $568M.
Based on Bleichroeder LP's 13F filing for Q4 2025, filed 13 Feb 2026.